The PI3K/AKT pathway, which is influenced by PI3K, PIP3, and AKT, plays an important role in hormone receptor-positive and HER2-positive breast cancers, contributing to tumor progression and treatment resistance (Agostinetto et al., 2021). Here, AKT1 is linked to neoplasm.